FDA Perspectives on Product Quality of Transderma Drug Delivery Systems | Virpax Pharmaceuticals

FDA Perspectives on Product Quality of Transderma Drug Delivery Systems

FDA Perspectives on Product Quality of Transderma Drug Delivery Systems

admin2020-10-17T09:31:17-04:00October 17th, 2020|

FDA Perspectives on Product Quality of Transderma Drug Delivery Systems

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma